Availability of Essential Medicines for Pediatric Oncology in Armenia

During recent decades substantial improvements has been documented in pediatric oncology and currently in high-income countries the survival of pediatric cancer is around 85%, however, the picture is totally different in low and middle income countries (LMIC), where around 80% of all pediatric cancer cases are documented: in LMIC pediatric cancer survival can range from 0 up to 50-60%. Among the others, one of the main challenges in LMIC is the availability of cancer medications.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research